An HRB Probiotic Strain for Infant and Adult Health
Supports Gut Wellbeing and Mental State
B. infantis M-63 is a versatile Human-Residential Bifidobacteria (HRB) probiotic strain renowned for its wide-ranging benefits, especially in infants and children. It excels in promoting the growth of Bifidobacterium in the gut, which is a key element in fostering gut health and supporting mental well-being for adults. What makes B. infantis M-63 even more impressive is its exceptional stability and cost-effectiveness. This strain is inherently robust, thriving even at room temperature.*
Originally isolated from infant feces, B. infantis M-63 is unique among gut bacteria in its immense capacity to utilize human milk oligosaccharide (HMOs), the component that is highly abundant in human breast milk. This exceptional ability allows B. infantis M-63 to colonize and adapt effectively to the human intestinal environment, particularly in infants. Consequently, B. infantis M-63 plays a pivotal role in shaping a gut microbiota rich in Bifidobacterium, significantly contributing to overall gut health and well-being.*
Moreover, B. infantis M-63 demonstrates promise in supporting mental health in adults with occasional abdominal discomfort. This effect is likely attributed to its ability to restore microbial balance and influence the gut-brain axis, underscoring its role in promoting holistic well-being.*
Resources
Explore our range of downloadable resources and gain insights into the crucial role of the gut microbiota, the thriving gut health market, and infographics and clinical studies backing B. infantis M-63.
B. infantis M-63 is a valued functional ingredient in a diverse range of products. Depending on your needs, we can accommodate a variety of product requests targeted at different consumer segments and health areas.*
Legislation can be varied by country when it comes to specific dosage and potential health claims of each strain.
Our regulatory team can help and advise you as to the appropriate individual markets permit. Morinaga’s global regulatory experts are in all major regions. We are committed to delivering expert advice and practical solutions to optimize your company’s success.
The information on this website is intended exclusively for business-to-business purposes and is not intended for end-consumer utilization. It is predicated upon our rigorous research and development endeavors and, to the best of our knowledge, is deemed reliable. Morinaga disclaims any liability arising from the utilization of its products, as the terms of employment are beyond our purview. The business-oriented information furnished herein should not be construed as a substitute for professional counsel. Prior to implementation, manufacturers and marketers are advised to ascertain compliance with local regulatory prerequisites, given that divergent claims may be permissible contingent upon the prevailing regulations in individual countries. This presentation is purely informative in a scientific context and does not constitute claims or marketing notifications within the jurisdiction of the United States.
Explore the Morinaga Probiotics Center to delve into key highlights showcasing the clinical efficacy of B. infantis M-63.
Be Inspired to Innovate with HRB Probiotics
Elevate your product quality with science-backed, functional ingredients.
